Free Trial
OTCMKTS:ECIA

Encision (ECIA) Stock Price, News & Analysis

$0.37
0.00 (0.00%)
(As of 09/13/2024 ET)
Today's Range
$0.37
$0.37
50-Day Range
$0.29
$0.42
52-Week Range
$0.12
$0.75
Volume
25 shs
Average Volume
27,626 shs
Market Capitalization
$4.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Encision

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

ECIA Stock Price History

ECIA Stock News Headlines

Encision Inc (ECIA)
Trump’s weapon lurks in abandoned America
Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…
Encision Reports Third Quarter Fiscal Year 2024 Results
Encision Reports Second Quarter Fiscal Year 2024 Results
Trump’s weapon lurks in abandoned America
Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…
Encision Signs Supplier Agreement with Human Xtensions
Encision Reports Third Quarter Fiscal Year 2023 Results
Encision Reports Second Quarter Fiscal Year 2023 Results
See More Headlines
Receive ECIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/15/2024
Today
9/14/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:ECIA
Employees
30
Year Founded
N/A

Profitability

Net Income
$-690,000.00
Pretax Margin
-8.07%

Debt

Sales & Book Value

Annual Sales
$6.59 million
Book Value
$0.15 per share

Miscellaneous

Free Float
7,511,000
Market Cap
$4.37 million
Optionable
Not Optionable
Beta
0.55
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Gregory J. Trudel (Age 63)
    CEO, President & Director
    Comp: $260.28k
  • Mr. David W. Newton (Age 77)
    Co-Founder, VP of Technology & Director
    Comp: $130.95k
  • Mr. Robert H. Fries (Age 75)
    Contract Chief Financial Officer
    Comp: $60.72k
  • Mr. Brian Jackman (Age 42)
    Vice President of Marketing
    Comp: $161.24k
  • Mr. Jason Johnson (Age 49)
    Vice President of Sales
  • Ms. Mala Ray (Age 65)
    VP, Controller, Treasurer & Corporate Secretary

ECIA Stock Analysis - Frequently Asked Questions

How have ECIA shares performed this year?

Encision's stock was trading at $0.4250 at the beginning of 2024. Since then, ECIA stock has decreased by 13.4% and is now trading at $0.3682.
View the best growth stocks for 2024 here
.

How were Encision's earnings last quarter?

Encision Inc. (OTCMKTS:ECIA) posted its quarterly earnings results on Monday, July, 15th. The medical device company reported ($0.03) EPS for the quarter. The medical device company earned $1.53 million during the quarter. Encision had a negative net margin of 9.16% and a negative trailing twelve-month return on equity of 29.13%.

How do I buy shares of Encision?

Shares of ECIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Encision own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), ATI (ATI) and Digital Turbine (APPS).

This page (OTCMKTS:ECIA) was last updated on 9/14/2024 by MarketBeat.com Staff

From Our Partners